3rd Annual mRNA-Based Therapeutics Summit

Multimodal Real-World Data for Accelerating Translational Research & De-Risking Drug Development: RNA Seq in Precision Oncology

Harmonized multimodal data sources can help researchers uncover actionable biomarkers and signatures of response or resistance

Whole transcriptome RNA sequencing unlocks a range of insights beyond the reach of traditional DNA-based methods, facilitating novel fusion detection, alternative splicing events, disease subtyping, and prognostic/ predictive signatures

Tempus is at the forefront of leveraging RNA sequencing data at scale to accelerate development and improve the probability of success of the next class of precision medicines